Skip to main content
Erschienen in: Reactions Weekly 1/2020

01.07.2020 | Case report

Enoxaparin-sodium

Bleeding: 3 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2020

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hakeam HA, et al. Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study. Clinical and Applied Thrombosis/Hemostasis 26: Jan 2020. Available from: URL: http://doi.org/10.1177/1076029620931194 Hakeam HA, et al. Anti-Factor Xa Levels in Low-weight Surgical Patients Receiving Enoxaparin for Venous Thromboembolism Prophylaxis: A Prospective Cohort Study. Clinical and Applied Thrombosis/Hemostasis 26: Jan 2020. Available from: URL: http://​doi.​org/​10.​1177/​1076029620931194​
Metadaten
Titel
Enoxaparin-sodium
Bleeding: 3 case reports
Publikationsdatum
01.07.2020
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2020
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-020-80857-0

Weitere Artikel der Ausgabe 1/2020

Reactions Weekly 1/2020 Zur Ausgabe

Case report

Antituberculars

Case report

Eculizumab

Case report

Antineoplastics

Case report

Multiple drugs